Cargando…
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
OBJECTIVES: 2-deoxy-2[(18)F]Fluoro-d-glucose (FDG) PET-CT has an emerging role in assessing response to neoadjuvant therapy in oesophageal cancer. This study evaluated FDG PET-CT in predicting pathological tumour response (pTR), pathological nodal response (pNR) and survival. METHODS: Cohort study o...
Autores principales: | Moore, Jonathan L., Subesinghe, Manil, Santaolalla, Aida, Green, Michael, Deere, Harriet, Van Hemelrijck, Mieke, Lagergren, Jesper, Chicklore, Sugama, Maisey, Nick, Gossage, James A., Kelly, Mark, Baker, Cara R., Davies, Andrew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121512/ https://www.ncbi.nlm.nih.gov/pubmed/36920518 http://dx.doi.org/10.1007/s00330-023-09482-7 |
Ejemplares similares
-
Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
por: Moore, J. L., et al.
Publicado: (2022) -
Discordant nodal staging identifies intermediate-risk group for overall survival in patients with cT3 oesophageal adenocarcinoma
por: Carder, Charles, et al.
Publicado: (2020) -
Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis
por: Bruce, David, et al.
Publicado: (2016) -
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment
por: Bosch, Karen D., et al.
Publicado: (2019) -
Cervical ultrasonography has no additional value over negative (18)F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer
por: Goense, Lucas, et al.
Publicado: (2017)